Title: Once weekly administration of etanercept 50 mg is efficacious and well tolerated in patients with moderate-to-severe plaque psoriasis: a randomized controlled trial with open-label extension
Authors: van de Kerkhof, P. C. M ×
Segaert, Siegfried
Lahfa, M
Luger, T. A
Karolyi, Z
Kaszuba, A
Leigheb, G
Camacho, F. M
Forsea, D
Zang, C
Boussuge, M. P
Paolozzi, L
Wajdula, J #
Issue Date: Nov-2008
Publisher: Blackwell publishing
Series Title: British Journal of Dermatology vol:159 issue:5 pages:1177-1185
Abstract: Background In previous studies, etanercept 25 mg twice weekly (BIW) or 50 mg BIW significantly reduced disease severity in patients with plaque psoriasis and demonstrated a favourable safety profile.
ISSN: 0007-0963
Publication status: published
KU Leuven publication type: IT
Appears in Collections:Laboratory of Dermatology
Laboratory of Dermatoimmunology (+)
× corresponding author
# (joint) last author

Files in This Item:

There are no files associated with this item.

Request a copy


All items in Lirias are protected by copyright, with all rights reserved.

© Web of science